Article Text

PDF
Atopic dermatitis in premature and term children
  1. B Kvenshagen1,
  2. M Jacobsen2,
  3. R Halvorsen3
  1. 1
    Oestfold Hospital Trust, Department of Pediatrics, Fredrikstad, Norway
  2. 2
    Oestfold Hospital Trust, Research and Development, Fredrikstad, and University of Oslo, Oslo, Norway
  3. 3
    Voksentoppen, Department of Pediatrics, Rikshospitalet-Radiumhospitalet Medical Senter, Oslo, Norway
  1. Dr B Kvenshagen, Department of Paediatrics, Oestfold Hospital Trust, 1603 Fredrikstad, Norway; bent-kv{at}online.no

Abstract

Objective: To investigate the prevalence of atopic dermatitis (AD) in premature compared with term children, the frequency of food allergy in children with AD, and the possible differences in prevalence of AD in children delivered by caesarean section compared with vaginally delivered children.

Design: Prospective follow-up study over 2 years.

Method: 609 children (193 premature and 416 term) were included. At 2 years, 512 children (161 premature and 351 term) participated. Children with symptoms consistent with AD/possible food allergy were examined, and the dermatitis was evaluated according to the SCORAD index. Skin prick test, specific IgE, elimination/challenge and DBPC challenge were performed.

Results: 18.6% (95/512) of the children (19.9% (32/161) premature and 17.9% (63/351) term) had a diagnosis of AD. The prevalence of adverse reactions to food in all the children with AD was 15.8% (15/95) (similar in preterm and term children). AD was found in 17.5% (30/171) of children delivered by caesarean section, and 19.1% (65/341) delivered vaginally

Conclusions: The prevalence of AD in the first 2 years of life was 18.6%, with no significant difference between preterm and term children. Adverse reactions to food were found in 15.8% (a similar prevalence in premature and term children). Mode of delivery did not affect prevalence of AD.

Statistics from Altmetric.com

Footnotes

  • Funding: This study received financial support from Helse Oest and Oestfold Hospital Trust, and grants from NAAF (The Norwegian Asthma- and Allergy Association).

  • Competing interests: None.

  • Ethics approval: Obtained.

  • Patient consent: Parental consent obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Atoms
    Howard Bauchner